Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

Patterson Acquires IDS

by Zacks Equity Research

September 13, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Patterson Dental, the dental division of Minnesota-based distributor of dental, veterinarian and rehabilitation medical supplies, Patterson Companies ( PDCO - Analyst Report ) , recently announced the acquisition of Iowa Dental Supply, LLC (IDS) a full service distributor of dental products. The financial details of this all-cash transaction were not disclosed.

Des Moines, Iowa-based IDS caters to Midwestern dental markets such as Iowa, South Dakota, Nebraska, Illinois and Missouri. Its long-established reputed sales force comprises 11 field representatives and equipment specialists.

The acquisition of IDS should boost Patterson Dental’s foothold in the Midwestern U.S. markets and provide a competitive edge to the company. Patterson competes head-to-head with Henry Schein Inc. ( HSIC - Snapshot Report ) in the dental market.

With IDS generating annual revenues of $13 million in 2011, management at Patterson Dental expect the deal to be modestly accretive in fiscal 2013. In its first quarter fiscal 2013 results, Patterson had forecast its earnings to be in the range of $2.10–$2.16 per share for the fiscal year. The company also anticipates that the integration process will be quick and hassle-free.

The acquisition is in line with the company’s long-term strategy to grow through internal expansion and acquisitions. Earlier, in April 2012, Patterson Medical acquired Australia-based distributor of rehabilitation, physiotherapy, and mobility products, Surgical Synergies Pty Ltd. for $10 million to expand its market size in Australia and New Zealand.

One of the two largest distributors of dental offerings in North America, Patterson Dental provides a wide range of consumables, equipment and software, and value-added services to its customers. Although patient demand for dental services was tepid at the height of recession, Patterson should benefit from the gradual recovery in the dental market.

We also remain upbeat about the prospects of the dental equipment business (especially CEREC) and the distribution agreement with Sirona Dental Systems ( SIRO - Snapshot Report ) . The company’s focused promotional activities should result in higher demand for this product category moving ahead.

However, consumable sales from the dental business are expected to be a drag due to the weak economy, high unemployment rate and lack of consumer confidence. We currently have a Neutral recommendation on the stock, which carries a short-term Zacks #3 Rank (Hold rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.